Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News

May & Baker signs deal to produce, sell Sanofi’s products in Nigeria, others

Fakoyejo OlalekanbyFakoyejo Olalekan
3 years ago
in Business News, Corporate deals
May & Baker Nigeria, has signed a partnership agreement with French pharmaceutical giant, Sanofi.
Share on FacebookShare on TwitterShare on Linkedin

Pharmaceutical company, May & Baker Nigeria, has signed a partnership agreement with French pharmaceutical giant, Sanofi to produce four brands of the latter.

The four Sanofi products, which would be manufactured by May & Baker Nigeria, will be sold in Nigeria and West African markets, a statement obtained by Nairametrics disclosed.

The tablets include Flagyl tablets and Suspension and Tarivid tablets, anti-infective medicines and Malareich tablets, an anti-malaria drug.

[READ ALSO: NASCON, Forte Oil, lead best performing stocks on Tuesday(Opens in a new browser tab)]

Why this matters: The National Agency for Foods and Drugs Administrations and Control (NAFDAC) had been calling for the production of imported drugs in Nigeria. This partnership between the duo is a step in that direction.

This positions Nigeria as an exporter of the drugs that have interested markets in West Africa. Apart from expanding the portfolio and services of May & Baker, Nigeria’s economy will also benefit in the trade partnership as it opens a new pharmaceutical market for both Nigeria and the company.

May & Baker signs deal to produce, sell Sanofi’s products in Nigeria, West Africa 

May & Baker is taking on the challenge of localising foreign brand products through its facility which it said can “produce six billion tablets and 37.5 million 60ml liquid medicines annually.”

The partnership is coming two months after May & Baker’s Director and Chairman of Board of Directors, Theophilus Danjuma, stepped down from his position in the company. Danjuma’s retirement was made known during May & Baker’s Board meeting. He was replaced by Senator Daisy Danjuma, who was first appointed to the May & Baker Board of Directors in 1999.

[READ MORE: Oando signs 2 gas supply agreement with NLNG)

What you need to know: May & Baker reported a decline in its top-line of 9.57% to N5.92 billion as against the N6.54 billion in nine months of 2018. The pharmaceutical unit recorded revenue of N5.86 billion in nine months of 2019, 6.95% lower than the corresponding period of 2018.

Related

Tags: May & Baker NigeriaNAFDACproduceproductsSanofisell

Comments 1

  1. Modu lawan says:
    December 18, 2019 at 8:56 pm

    The Bord of trustees we are proud on it to make our nation economic growth

    Reply

Leave a Reply Cancel reply

HFM
Mega Millions
Mega Millions
Patricia





NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Atiku asks CBN not to extend naira swap deadline, says vote buyers behind extension plot
  • FG reacts to allegations of anti-Tinubu elements in Aso Rock by Governor El-Rufai
  • NGX closes positive as investors gain N142 billion

Follow us on social media:

Recent News

Atiku asks CBN not to extend naira swap deadline, says vote buyers behind extension plot

Atiku asks CBN not to extend naira swap deadline, says vote buyers behind extension plot

February 1, 2023
FG reacts to allegations of anti-Tinubu elements in Aso Rock by Governor El-Rufai

FG reacts to allegations of anti-Tinubu elements in Aso Rock by Governor El-Rufai

February 1, 2023
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Lifestyle
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds

© 2023 Nairametrics